The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

It found that people on GLP-1 drugs like Wegovy and Ozempic reported eating fewer processed foods, red meat and sugary drinks ...

The president lets slip private medical information about a wealthy businessman, telling reporters, “Most of you would’ve heard of him.” ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

Investing.com - Global pharmaceutical stocks tumbled Monday after U.S. President Donald Trump announced plans to sign an ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.

The effects they have on your body and mind vary, as Wegovy flips one appetite switch in your brain, while Mounjaro flips two ...

Sophia Umansky—the daughter of Kyle Richards and Mauricio Umansky—doubled down on her decision to take Mounjaro, despite ...

Novo Nordisk's competitive position is strengthening, driven by strong sales growth in Wegovy, Ozempic, and rare diseases.

Our writer thinks these two shares are well worth checking out for investors targeting a growing stream of passive income over the next few years.

Both Mounjaro and Wegovy are GLP-1 receptor agonists. So, GLP-1 is basically usually released after eating, sending a signal to your brain that you’re full up and delaying the e ...